Title: Prevalence and Risk Factors of Incomplete Surgical Closure of the Left Atrial Appendage on Follow-up Transesophageal EchocArdiogram
Credits: Billy Lin, Brian D. Jaros, Eugene A. Grossi, Muhamed Saric, Michael S. Garshick, Robert Donnino
Title: Clinical Impact of Saline Volume Infused Through Irrigated-Tip Ablation Catheter in Low Acuity Paroxysmal Atrial Fibrillation Ablation Patients
Title: Symptom/rhythm correlation with patient owned device: Insights into practice and challenges
Credits: Mohammed Shurrab, Anatoly Langer, Eugene Crystal, David Newman
Title: Determining esophageal anatomy with a new electroanatomical mapping system
Credits: Diego Chemello MD, Imad Hameedullah BSc RCVT, Anandaraja Subramanian MD, Eugene Downar MD FRCPC
Title: The Autonomic Nervous System and Atrial Fibrillation: The Roles of Pulmonary Vein Isolation and Ganglionated Plexi Ablation
Credits: Benjamin J. Scherlag, PhD, Hiroshi Nakagawa, M.D, Ph.D, Eugene Patterson, PhD, Warren M. Jackman, MD, Ralph Lazzara, MD, Sunny S. Po, MD, PhD
Affiliation: Dr. Sameer Bansilal is a clinician and investigator with a broad range of expertise in cardiovascular medicine and outcomes research on a global scale. Dr. Bansilal is currently an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai and an Attending Physician in the Mount Sinai Cardiovascular Institute. Prior to this he was investigator at the TIMI Study Group at Brigham and Women’s Hospital, Boston, MA, founded by Eugene Braunwald, MD. Dr. Bansilal earned his medical degree from University of Mumbai, India and completed his residency training in Internal Medicine at New York Methodist Hospital, New York. He went on to complete a research fellowship followed by a clinical cardiology fellowship at Mount Sinai, New York under the tutelage of Valentin Fuster, M.D, Ph.D. During this time, Dr. Bansilal obtained a Masters in Clinical Research from the Mount Sinai-NYU Program and additional training at the Harvard School of Public health through the program in clinical effectiveness. Dr. Bansilal has experience with federally funded trials (FREEDOM) and multiple pharmaceutical sponsored trials (PEGASUS TIMI-54, DECLARE TIMI-58) through his work in New York and Boston. Dr. Bansilal’s research interests include evaluation of therapies for coronary disease, diabetes, atrial fibrillation and valvular heart disease in global populations. His special interests include advanced trial design and trial methodology. His clinical interests center on patients with diabetes, coronary disease, atrial fibrillation, valvular disease and asymptomatic patients with various heart disorders.
ISLAA 2022-Left Atrial Appendage
Dr. Dhanunjay Lakkireddy, MD, F.A.C.C, FHRS, The Kansas City Heart Rhythm Institute (KCHRI), KS, USA.
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...